Topic
Multidistrict Litigation
454 published works
Drug & Device Law
MDLs, Delays, and Rule 11
Last week we alluded to the utility of bench-bar conferences. As if to prove that point, we spent Thursday and Friday at a conference on Multidistrict Litigations. The conference was…
Duane Morris Products Liability
Updated Federal Rules Can Improve Product Liability MDLs
By Duane Morris
In the evolving universe of multidistrict litigation, begun in the antitrust cases against major electronics manufacturers in the 1960s, federal courts have developed varying approaches to fulfilling their responsibilities to…
Drug & Device Law
15 Years After the Fact, This MDL Remand Case Is Still at the Pleading Stage
By Bexis
The title is ridiculous, but unfortunately true. Muldoon v. DePuy Orthopaedics, Inc., is a suit over “hip-replacement surgery conducted in 2007.” 2024 WL 1892907, at *1 (N.D. Cal. April 30,…
TortsProf Blog
Goldberg on the Need for Early Vetting in MDLs
The Federal Rules Advisory Committee is considering a new rule of civil procedure to govern MDLs. Several years ago, the Committee issued a report estimating that approximately 20%-30% of claims…
Drug & Device Law
Paraquat MDL Court Bounces Plaintiffs with “Implausible Theories of Proof”
In early Summer we will be attending yet another bench and bar conference on Multidistrict Litigations. The organizer of the conference recently asked us to switch from a panel focusing…
TortsProf Blog
MDL for Weight Loss and Diabetes Drugs in Philly
Dozens of lawsuits accuse Novo Nordisk or Eli Lilly, manufacturers of GLP-1 agonists, of failure to warn about the side effects of their drugs. GLP-1 agonists are used to treat…
Regulatory Oversight
State Antitrust Enforcement Venue Act: Recent Updates
By Drew Mann, McKayla Riter, Rachel Buck
Just over a year has passed since President Biden signed the State Antitrust Enforcement Venue Act (the State AG Venue Act or Act) into law, and state attorneys general (AG)…
Drug & Device Law
MDL Mischief
In the last couple of years we have gone to plenty of Multidistrict Litigation (MDL) court conferences. We’ve also gone to plenty of bench-bar conferences about MDLs. From the defense…
Drug & Device Law
Enough Is Enough In Taxotere Remand Case
The unwieldy and sometimes unfair nature of multidistrict litigation has become a recurring theme on the DDL Blog. We have long commented on the “if you build it, they will…
Drug & Device Law
Are MDLs Fields of Dreams (or Nightmares)?
Last week Bexis posted a link to his comment on draft proposed Federal Rule of Civil Procedure 16.1, which deals with multidistrict litigations (MDLs). If you haven’t read proposed Rule…